Globally, 37.9 million people were living with HIV at the end of 2018 (Organization, 2018). Cancer is a major cause of mortality and morbidity in AIDS patients and chronically HIV-infected people. With the aid of combination Antiretroviral Therapy (ART), people living with HIV (PLWH) have a longer life span. However, because the virus is not completely eradicated, PLWH under antiretroviral therapy may have an increased risk of Non-AIDS-Defining Cancers (NADCs) (Deeks et al., 2013). As defined by NCI, NADCs include Hodgkin lymphoma and cancers of the mouth, throat, liver, lung and anus. Besides HIV infection, other factors, such as older age, infection with other viruses and heavy alcohol or tobacco use, may also increase the risk of developing an NADC (Institute, 0000). Patients with HIV/AIDS are reported to have a two to four-fold increase in risk for head and neck cancers (Powles et al., 2009). Compared with uninfected subjects, the risk of HIV-infected patients with lung cancer has several folds increased (Chaturvedi et al., 2007). Multiple mechanisms contribute to this phenomenon, including longer life expectancy, control of oncogenic infections and exposure to carcinogens (Wang et al., 2014).